全文获取类型
收费全文 | 4236篇 |
免费 | 0篇 |
专业分类
电工技术 | 2篇 |
化学工业 | 18篇 |
建筑科学 | 13篇 |
轻工业 | 2篇 |
无线电 | 9篇 |
一般工业技术 | 8篇 |
冶金工业 | 4170篇 |
原子能技术 | 1篇 |
自动化技术 | 13篇 |
出版年
2022年 | 2篇 |
2019年 | 1篇 |
2016年 | 1篇 |
2015年 | 1篇 |
2014年 | 2篇 |
2013年 | 12篇 |
2012年 | 1篇 |
2010年 | 1篇 |
2009年 | 1篇 |
2008年 | 3篇 |
2007年 | 3篇 |
2006年 | 3篇 |
2003年 | 6篇 |
2002年 | 3篇 |
2001年 | 4篇 |
2000年 | 1篇 |
1999年 | 129篇 |
1998年 | 1292篇 |
1997年 | 710篇 |
1996年 | 466篇 |
1995年 | 269篇 |
1994年 | 194篇 |
1993年 | 261篇 |
1992年 | 46篇 |
1991年 | 51篇 |
1990年 | 50篇 |
1989年 | 75篇 |
1988年 | 63篇 |
1987年 | 68篇 |
1986年 | 44篇 |
1985年 | 50篇 |
1983年 | 9篇 |
1982年 | 17篇 |
1981年 | 29篇 |
1980年 | 27篇 |
1979年 | 2篇 |
1978年 | 6篇 |
1977年 | 110篇 |
1976年 | 210篇 |
1975年 | 6篇 |
1974年 | 2篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1964年 | 1篇 |
1961年 | 1篇 |
1955年 | 1篇 |
排序方式: 共有4236条查询结果,搜索用时 0 毫秒
991.
992.
993.
994.
995.
JD Meiss 《Canadian Metallurgical Quarterly》1986,34(3):2375-2383
996.
997.
998.
999.
CL Davis DR Gretch JD Perkins AW Harris MH Wener CE Alpers R Lesniewski W Lee C dela Rosa RJ Johnson 《Canadian Metallurgical Quarterly》1995,1(3):166-175
Hepatitis C virus (HCV) infection may be associated with extrahepatic illness including renal disease. We investigated the clinical and virological characteristics of three patients who developed a mesangial proliferative and sclerosing glomerulopathy alone or in association with membranoproliferative glomerulonephritis after liver transplantation for end-stage liver disease secondary to HCV infection. Using polymerase chain reaction technology and the IgM RIBA assay, viral load, genotype and IgM antibody response to HCV in the setting of glomerulonephritis was evaluated. Within 1 year of transplantation, the patients showed decreased renal function, proteinuria and recurrent hepatitis C liver disease. Likewise, HCV viral load increased following transplantation, whereas the viral genotypes remained unchanged. Although the first patient presented with classic type II cryoglobulinemia in association with glomerulonephritis, the second patient developed an IgM directed specifically against the hepatitis C core antigen. The third patient developed a low-titered IgM directed against the hepatitis C core antigen with rheumatoid factor activity but without cryoglobulinemia. All of the patients show IgM in glomerular capillary walls by biopsy. One patient has shown a clinical response to interferon (IFN) alfa-2b therapy without evidence of hepatic allograft rejection. The second and third patients have not responded to IFN or developed hepatic rejection. This study suggests that HCV-associated glomerulonephritis may complicate liver transplantation in conjunction with the production of increased amounts of IgM of variable specificity. The posttransplant setting may provide a unique situation in which to investigate the specific requirements for the onset of renal disease. 相似文献
1000.
A Kessinger MR Bishop JD Jackson B O'Kane-Murphy JM Vose PJ Bierman EC Reed PI Warkentin JO Armitage JG Sharp 《Canadian Metallurgical Quarterly》1995,23(7):609-612
A trial to determine the usefulness of recombinant human erythropoietin (rhEpo) as a mobilizing cytokine for patients with previously treated relapsed malignancies was performed. An initial peripheral stem cell apheresis collection was conducted during steady-state hematopoiesis for each patient to provide baseline data. rhEpo, 200 U/kg/day, was administered subcutaneously until the last apheresis procedure was completed. Immediately after the fourth daily dose of Epo, apheresis procedures were resumed and continued beyond five collections, when necessary, to accrue a total of 6.5 x 10(8) mononuclear cells (MNCs)/kg. Eight female and four male patients (median age = 44 years) were evaluated. Five to 14 (median = 8) apheresis procedures were performed for each patient. Toxicity attributable to Epo administration was negligible. Mobilization effects, as determined by an increase in the number of colony-forming units granulocyte/macrophage (CFU-GM) and burst-forming units-erythroid (BFU-E) in the apheresis products after Epo administration, were observed in all patients. Nine patients received high-dose chemotherapy and Epo-mobilized peripheral stem cell transplantation (PSCT). Beginning the day of the transplant, GM-CSF was administered until neutrophil recovery was satisfactory. The median time to recover 0.5 x 10(9)/L granulocytes was 16 days after PSCT. Epo appears to have mobilization properties. Further studies are needed to determine the clinical usefulness of Epo as a mobilizing cytokine. The addition of Epo to other mobilizing cytokines may provide increased effectiveness without adding toxicity. 相似文献